Collagen abnormalities in the skin and spinal cord have been reported in am
yotrophic lateral sclerosis (ALS) patients, Serum carboxyterminal propeptid
e of type procollagen (PICP) and the carboxyterminal cross-linked telopepti
de of type I collagen (ICTP) reflect type I collagen synthesis and degradat
ion, respectively, However, there has been no study concerning PICP or ICTP
in ALS. We studied collagen contents of the skin and measured serum levels
of PICP and ICTP in patients with ALS and control subjects, Serum PICP lev
els were significantly lower in ALS patients than in controls. Serum ICTP l
evels were significantly higher in ALS patients than in controls, and there
was an appreciable positive correlation between serum ICTP levels and the
duration of illness in ALS patients, In ALS patients, the collagen content
of the skin was significantly smaller than in controls and indicated a prog
ressive decrease in relation to illness. In addition, there was a significa
nt negative correlation between serum ICTP concentrations and the collagen
content of the skin in ALS patients. These data suggest that increased ICTP
levels and decreased serum PICP levels may reflect unique changes in the s
kin, with a predominance of degradation compared to the synthesis of type I
collagen in ALS, Copyright (C) 2000 S. Karger AG, Basel.